Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

National Center for Tumor Diseases | Researchclopedia

Back to institutions

National Center for Tumor Diseases

Heidelbergfunder

11,867

Works

1,573,472

Citations

474

h-index

Top Research Topics

Cancer Genomics and Diagnostics Cancer Immunotherapy and Biomarkers Glioma Diagnosis and Treatment

Top Researchers

Guido Kroemer Inserm

2,303 works369,261 citationsh-index: 283

Recent Research

<i>Erratum</i> to: “Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial”

R. Schlenk,Pau Montesinos,et al.

20260 citations

Multiple Myeloma Research and Treatments

CAR-T cell therapy research

Immunotherapy and Immune Responses

Genetic factors in colorectal cancer

Radiomics and Machine Learning in Medical Imaging

Cancer Treatment and Pharmacology

Breast Cancer Treatment Studies

Cancer survivorship and care

Lung Cancer Treatments and Mutations

Hermann Brenner German Cancer Research Center

3,231 works323,240 citationsh-index: 202

Dirk Schadendorf National Center for Tumor Diseases

2,376 works221,942 citationsh-index: 182

David J. Hunter The University of Sydney

2,466 works209,575 citationsh-index: 204

Jedd D. Wolchok Cornell University

1,393 works204,819 citationsh-index: 173

Eric Van Cutsem Hebron University

1,824 works173,522 citationsh-index: 174

151P Variables influencing biopsy adherence: Lessons from the cancer core europe (CCE) clinical trial basket of baskets

M. Rotxes Costa,F. Opdam,et al.

20260 citations

6P TROP-2 as a therapeutical target in gastrointestinal tumors

L. Kabisch,P.K.M. Hoffmeister-Wittmann,et al.

20260 citations

Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma

Reinhard Dummer,Shahneen Sandhu,et al.

20260 citations

MyCODE: A prospective evaluation of Lay-language Molecular Tumor Board Protocols in Precision Oncology

Ina Pretzell,Anke Fleischhauer,et al.

20260 citations

Presence of <i>IDH2</i> and <i>TP53</i> mutations significantly reduces survival of patients with chondrosarcoma

Anne Weidlich,Klaus‐Dieter Schaser,et al.

20260 citations